Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protection of<i>Aotus</i>Monkeys by<i>Plasmodium falciparum</i>EBA‐175 Region II DNA Prime–Protein Boost Immunization Regimen

15 Jan 2001

Abstract excerpt

Aotus monkeys received 4 doses of Plasmodium falciparum EBA-175 region II vaccine as plasmid DNA (Dv-Dv) or recombinant protein in adjuvant (Pv-Pv) or as 3 doses of DNA and 1 dose of protein (Dv-Pv). After 3 doses, antibody titers were approximately 10(4) in DNA-immunized monkeys and 10(6) in protein-immunized monkeys. A fourth dose did not significantly boost antibody responses in the Dv-Dv only or Pv-Pv only...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Research and Treatment
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11110648
DOI: 10.1086/317933

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protection of<i>Aotus</i>Monkeys by<i>Plasmodium falciparum</i>EBA‐175 Region II DNA Prime–Protein Boost Immunization RegimenPMID 11110648Read ↗

Development of novel Aotus nancymaae Non-human primate model for the evaluation of Plasmodium vivax blood stage vaccines and immunoprophylacticsSemantic proximity Read ↗

Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium VivaxSemantic proximity Read ↗

Sterile protection against <i>Plasmodium vivax</i> malaria by repeated blood stage infection in a non-human primate modelSemantic proximity Read ↗

Single-Dose Protection against<i>Plasmodium berghei</i>by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron ASemantic proximity Read ↗

A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus MonkeysSemantic proximity Read ↗

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3Semantic proximity Read ↗

Clinical and Parasitological Protection in a Leishmania infantum-Macaque Model Vaccinated with Adenovirus and the Recombinant A2 AntigenSemantic proximity Read ↗

IMMUNOGENICITY AND PROTECTIVE EFFICACY OF RECOMBINANT VACCINE BASED ON THE RECEPTOR-BINDING DOMAIN OF THE PLASMODIUM VIVAX DUFFY BINDING PROTEIN IN AOTUS MONKEYSSemantic proximity Read ↗

Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.Semantic proximity Read ↗

Vaccination of Monkeys with RecombinantPlasmodium falciparumApical Membrane Antigen 1 Confers Protection against Blood-Stage MalariaSemantic proximity Read ↗

Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length<i>Plasmodium falciparum</i>Circumsporozoite ProteinSemantic proximity Read ↗

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.